XTalks

MAY 22, 2023

It’s an extremely important factor I consider in my therapeutic process of restoring their natural beauty and appearance,” said Macrene Alexiades, MD, PhD, dual US-EU board-certified dermatologist, SkinVive by Juvéderm lead investigator and author of the clinical trial published in Dermatologic Surgery.

Filler 92

Filler FDA Approval Dermatology In-Vivo 92

Pharma Marketing Network

APRIL 4, 2022

The American Academy of Dermatology (AAD) held its annual conference last weekend, and it was my privilege to be in attendance. As COVID-19 had put the brakes on the show for the past two years, that same sentiment was shared by most of the attendees and exhibitors this year.

Dermatology 52

Dermatology Cosmetics Pharma Companies Branding 52

The Pharma Data

FEBRUARY 5, 2021

” said Dr. Sabrina Fabi , Board Certified Dermatologist and Associate Research Director at Cosmetic Laser Surgery in San Diego. American Society for Dermatologic Surgery (ASDS) consumer survey on cosmetic dermatologic procedures 2018 available at [link]. N= 3,525 total study population.

Dermatology 52

Dermatology Cosmetics Allergies Production 52

Roots Analysis

JANUARY 3, 2024

Medical aesthetics is a growing area of modern medicine that focuses on improving the cosmetic appearance of an individual through various medical treatments. However, Botulinum toxin was the real game-changer when it was approved for cosmetic use by the FDA in 2002.

Filler 40

Filler Cosmetics Production Dermatology 40

pharmaphorum

DECEMBER 9, 2021

JLABS alumnus Dermala is a consumer dermatology company that is using the human microbiome to develop more personalised treatments for skin conditions such as acne, which JJDC invested in as part of their series A funding. Self care, skin health and technology innovation. Two recent successes are Dermala and Remedee Labs.

Allergies 105

Allergies Life Science Development Scientist 105

Olympian Clinical Research

JUNE 2, 2021

At OCR we’re committed to educating the public and raising awareness about diseases like eczema, so today we’re taking some time to walk you through everything you need to know about this common dermatology condition. Triggers can vary patient by patient, but some of the most common eczema triggers are: Cosmetic products. Fragrances.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

Triage Cancer

MARCH 9, 2021

CareCredit 26.99% 6, 12, 18, and 24 months Primary & Urgent, Chiropractic, Cosmetic, Day Spa, Dentistry, Dermatology, Specialists, Hearing, LASIK & Vision Care, Veterinary, Weight Loss. Three examples of medical credit cards are the CareCredit credit card, Wells Fargo Health Advantage Credit Card, and the AccessOne MedCard. .

Dermatology 52

Dermatology Cosmetics Research 52

XTalks

JUNE 17, 2024

While Hugel has not disclosed the price for Letybo at this time, it is estimated that similar treatments, such as Botox Cosmetic, can range from $325 to $600. Hugel is currently in the final stages of refining its go-to-market strategy, with plans to commercially launch Letybo soon, by mid-year.

FDA Approval 52

FDA Approval Marketing Botox Clinical Trials 52

The Pharma Data

NOVEMBER 10, 2020

VPX638 formulation for painful inflammatory conditions is among Vapogenix’s platform of novel, patented formulations of VAs, being developed for the localized treatment of a broad range of painful conditions, including wounds, combat-related injuries, and medical procedures such as needle injections, needle biopsies and cosmetic dermatology.

Development 40

Development Dermatology Cosmetics Production 40

Druggist

OCTOBER 25, 2020

Glycerin is a commonly used ingredient in the cosmetic industry, which helps to ‘hydrate’ the skin by attracting and binding of the water. Buy on Amazon Price incl. delivery Glycerin is one of the main ingredients of Virasoothe Cooling Gel. E45 Itch Relief Cream can be used in children and infants over the age of one month.

Production 52

Production Pharmacy Licensing Licensing 52

The Pharma Data

MARCH 4, 2021

associate professor of Dermatology at Yale School of Medicine. AA is the second potential treatment indication in dermatology for baricitinib after AD. “For patients who suffer from alopecia areata, it is not a cosmetic condition, it is a devastating autoimmune disease that can have significant psychological effects.

Trials 52

Trials Development Dermatology Clinical Trials 52

XTalks

MAY 25, 2023

In this episode, Vera talked about the US Food and Drug Administration’s (FDA) approval of Veozah (fezolinetant), the new type of drug for menopausal hot flashes and night sweats. It is estimated that around 60 to 80 percent of women experience vasomotor symptoms (hot flashes, night sweats, etc.) during or after the menopausal transition.

Filler 52

Filler Life Science FDA Approval Drugs 52

The Pharma Data

NOVEMBER 4, 2020

(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

XTalks

AUGUST 2, 2023

2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy. The list price of a four-week supply of Humira was reported to be $6,922.62 billion in 2022.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

NOVEMBER 4, 2020

Initial data from an ongoing long-term, open label extension study with CTP-543 were presented in the late-breaking news session at the European Academy of Dermatology and Venereology (EADV) Virtual Congress on October 29, 2020. Published Findings on Alopecia Areata Burden of Disease in Journal of Investigative Dermatology.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52